St. Jude Medical announces CRT patients showed improvement in the RHYTHM ICD study

St. Paul, MN, March 9, 2004 -- St. Jude Medical, Inc. (NYSE: STJ) announced today that data from its RHYTHM (Resynchronization HemodYnamic Treatment for Heart Failure Management) ICD clinical trial showed a statistically significant improvement in peak VO2 and exercise duration for patients treated with cardiac resynchronization therapy (CRT). All prospectively defined primary safety and efficacy endpoints of the study were successfully met. The announcement was made today in conjunction with the American College of Cardiology's 2004 Scientific Session in New Orleans, Louisiana.

"The Epic HF ICD evaluated in this study effectively combines pacemaker therapy, defibrillation therapy and left-heart stimulation to treat the complexities of heart failure," said Kyong T. Turk, M.D., of the Nebraska Heart Institute, Lincoln, Nebraska, who enrolled the most patients in the RHYTHM clinical study. "These multiple sophisticated therapies in one compact, easy to implant device give me significant flexibility to optimize patient care."

The primary efficacy endpoint of the RHYTHM ICD study was improvement in cardiac function as measured by patient peak VO2 during cardiopulmonary exercise testing. The clinical trial was sized based on an expectation that the CRT arm of the study would show a 1.6 ml/kg/min improvement in peak VO2 compared with the control group, which did not have the CRT feature activated. The actual observed improvement level for CRT compared to control was 1.93 ml/kg/min, which was statistically significant (p=0.001). Secondary endpoints concerning NYHA class and Quality of Life were also statistically significantly improved with CRT (p=0.048 and p=0.009, respectively), with the six minute walk test demonstrating a strong trend toward significance (p=0.07). The study evaluated resynchronization effectiveness, defibrillation system efficacy, defibrillation system safety and left ventricle lead performance.

"This is a signif

Contact: mechal weiss
Edelman Public Relations

Page: 1 2 3

Related medicine news :

1. Medically supervised drug injection facilities safer for users
2. Medical molecules designed to respond to visible light that can penetrate tissue
3. Philanthropist Paul F. Glenn launches labs for aging research at Harvard Medical School
4. UCLA Medical Center becomes first hospital to introduce remote presence robots in ICU
5. New data on Orqis Medicals Cancion CRS to be reported at ACC
6. Medical technologies may hinder rather than help newborn survival
7. Medical meeting to feature research findings and disease prevention and health promotion sessions
8. LA BioMed Medical/Research briefs January 2005
9. Medical negligence system is secretive, unaccountable and unregulated
10. Dartmouth Medical School receives $1.6 million in AIDS funding
11. LA BioMed Medical/Research Briefs December 2004

Post Your Comments:

(Date:9/3/2020)... (PRWEB) , ... September 03, 2020 , ... ... it is sponsoring the American Foundation for Suicide Prevention’s (AFSP) annual signature event, ... million people across hundreds of U.S. cities to raise awareness of suicide prevention. ...
(Date:9/3/2020)... ... September 03, 2020 , ... ... Sunrise Technologies WALI wireless parking lot controller. This advanced LED wireless dimming controller, ... light trespass, and protecting the night sky against light pollution. Leo Smith, the ...
(Date:9/1/2020)... ... September 01, 2020 , ... Feeding Matters , the ... with Pediatric Feeding Disorder (PFD), is pleased to announce that the U.S. Centers for ... code (R code) in the next edition of the U.S. International Classification of ...
(Date:8/31/2020)... ... August 31, 2020 , ... The Lymphoma Research ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... of Blood Cancer Awareness Month (BCAM) and its international Light it Red ...
(Date:8/31/2020)... ... August 31, 2020 , ... Genesis Chiropractic Software and ... the launch of its integrated, HIPAA compliant, telehealth solution, available to US-based clients ... under 90 seconds. , According to the U.S. Department of Health & ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... WILMINGTON, Mass. (PRWEB) , ... September 02, 2020 ... ... in handheld 1064nm Raman technology, will moderate a roundtable discussion among industry professionals ... The roundtable will be hosted by American Pharmaceutical Review and will ...
(Date:9/2/2020)... , ... September 02, 2020 , ... U.S. Dermatology ... Lee . Dr. Lee will work at Bethesda Dermatopathology Lab. , ... B.A. from the University of California, Berkley. He went on to receive his M.D. ...
(Date:9/1/2020)... N.Y. (PRWEB) , ... September 01, 2020 , ... ... dermatologist, and Director of Cosmetics and Laser Surgery at the University of Rochester ... Dermatologic Surgery fellowship at SkinCare Physicians in Boston, with clinical faculty from the ...
Breaking Medicine Technology:
Cached News: